When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...

Add Yahoo as a preferred source to see more of our stories on Google. While certain health conditions like allergies are discussed a lot in public, others like overactive bladder don’t come up a lot ...

Urodynamics plus comprehensive clinical assessment (CCA) showed no superiority over CCA alone in treating women with refractory overactive bladder symptoms. CCA for female incontinence offered equally ...

Bright Uro Inc. this month received Food and Drug Administration approval for its first product, the Glean Urodynamics System. It’s the biggest milestone to date for the Irvine medical device maker ...

Lately, millions have been Googling for information about pelvic floor dysfunction. And it's no wonder. After menopause, around 50% of women develop symptoms that can be minor (peeing a bit when we ...

Researchers from the University of Birmingham’s Bladder Cancer Research Centre have used a new method to detect chemical changes in the DNA in an individual’s urine sample - epigenetic changes, called ...

PredicineCARE is a urine-based NGS assay under FDA review for bladder cancer companion diagnostics, detecting genetic alterations in cancer-related genes. The test uses a capture-based method to ...

May is Bladder Cancer Awareness Month and this test, which is supported by charity Action Bladder Cancer, could reduce suffering for thousands of patients. I am delighted that GALEAS Bladder is ...

Having trouble with bladder control? There might be an app for that, researchers say. Female veterans suffering from urinary incontinence received effective relief using a smartphone app called ...

Regularly delaying urination may increase susceptibility to urinary tract infections (UTIs) and bladder symptoms in women, highlighting the importance of timely voiding habits.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc (VCYT). (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that at least 18 abstracts focused on its Decipher Prostate ...